← All trials
NCT00935987
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2009
- Primary completion
- Apr 1, 2012
- Completion date
- Apr 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 166
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Gilead SciencesLead sponsor
- Mayo ClinicOverall official - principal investigator
- Melbourne HealthOverall official - principal investigator
- Stanford UniversityOverall official - principal investigator
- McGill UniversityOverall official - principal investigator
- Harvard UniversityOverall official - principal investigator
- Mayo ClinicStudy chair
- University of TorontoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.